Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
2002 1
2005 1
2007 2
2008 1
2009 1
2010 1
2011 2
2012 3
2014 1
2017 2
2018 1
2019 2
2020 2
2021 3
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
BBCIC Research Network Analysis of First-Cycle Prophylactic G-CSF Use in Patients Treated With High-Neutropenia Risk Chemotherapy.
Pawloski PA, McDermott CL, Marshall JH, Pindolia V, Lockhart CM, Panozzo CA, Brown JS, Eichelberger B. Pawloski PA, et al. J Natl Compr Canc Netw. 2021 Aug 16:jnccn20268. doi: 10.6004/jnccn.2021.7027. Online ahead of print. J Natl Compr Canc Netw. 2021. PMID: 34399406
BACKGROUND: Chemotherapy-induced febrile neutropenia (FN) is prevented or minimized with granulocyte colony-stimulating factors (G-CSFs). Several G-CSF biosimilars are approved in the United States. ...We assessed hospitalizations for FN, availability of absolute ne …
BACKGROUND: Chemotherapy-induced febrile neutropenia (FN) is prevented or minimized with granulocyte colony-stimulating factors (G-CS …
Patient Characteristics and Utilization Patterns of Short-Acting Recombinant Granulocyte Colony-Stimulating Factor (G-CSF) Biosimilars Compared to Their Reference Product.
Mendelsohn AB, Marshall J, McDermott CL, Pawloski PA, Brown JS, Lockhart CM. Mendelsohn AB, et al. Drugs Real World Outcomes. 2021 Jun;8(2):125-130. doi: 10.1007/s40801-021-00228-9. Epub 2021 Jan 30. Drugs Real World Outcomes. 2021. PMID: 33517548 Free PMC article.
BACKGROUND: Data on short-acting recombinant granulocyte colony-stimulating factor (G-CSF) biosimilar utilization from claims data in the USA are limited. OBJECTIVE: To evaluate patient baseline characteristics and utilization patterns for short-acting G-CSF product …
BACKGROUND: Data on short-acting recombinant granulocyte colony-stimulating factor (G-CSF) biosimilar utilization from claims data in …
Identification of cancer chemotherapy regimens and patient cohorts in administrative claims: challenges, opportunities, and a proposed algorithm.
Lockhart CM, McDermott CL, Mendelsohn AB, Marshall J, McBride A, Yee G, Li MS, Jamal-Allial A, Djibo DA, Vazquez Benitez G, DeFor TA, Pawloski PA. Lockhart CM, et al. J Med Econ. 2023 Jan-Dec;26(1):403-410. doi: 10.1080/13696998.2023.2187196. J Med Econ. 2023. PMID: 36883996 Free article.
This study describes the challenges and successes during algorithm development to identify cancer cohorts and multi-agent chemotherapy regimens from claims data to perform a comparative effectiveness analysis of granulocyte colony stimulating factor (G-CSF) use. METHODS: U …
This study describes the challenges and successes during algorithm development to identify cancer cohorts and multi-agent chemotherapy regim …
Performance of existing and novel surveillance case definitions for COVID-19 in household contacts of PCR-confirmed COVID-19.
Reses HE, Fajans M, Lee SH, Heilig CM, Chu VT, Thornburg NJ, Christensen K, Bhattacharyya S, Fry A, Hall AJ, Tate JE, Kirking HL, Nabity SA; U.S. COVID-19 Household Investigation Team. Reses HE, et al. BMC Public Health. 2021 Sep 25;21(1):1747. doi: 10.1186/s12889-021-11683-y. BMC Public Health. 2021. PMID: 34563163 Free PMC article.
METHODS: We assessed diagnostic performance of existing cases definitions (e.g. influenza-like illness, COVID-like illness) using symptoms reported from 185 household contacts to a PCR-confirmed case of COVID-19 in Wisconsin and Utah, United States. ...
METHODS: We assessed diagnostic performance of existing cases definitions (e.g. influenza-like illness, COVID-like illness) using sym …
Predicting neutropenia risk in patients with cancer using electronic data.
Pawloski PA, Thomas AJ, Kane S, Vazquez-Benitez G, Shapiro GR, Lyman GH. Pawloski PA, et al. J Am Med Inform Assoc. 2017 Apr 1;24(e1):e129-e135. doi: 10.1093/jamia/ocw131. J Am Med Inform Assoc. 2017. PMID: 27638907 Free PMC article.
The guidelines suggest that oncologists consider patient-specific characteristics when prescribing granulocyte-colony stimulating factor (G-CSF) prophylaxis; however, a mechanism to quantify individual patient risk is lacking. ...
The guidelines suggest that oncologists consider patient-specific characteristics when prescribing granulocyte-colony stimulating factor ( …
Evaluation of Commercial Assays for Single-Point Diagnosis of Pertussis in the US.
Pawloski LC, Plikaytis BD, Martin MD, Martin SW, Prince HE, Lapé-Nixon M, Tondella ML. Pawloski LC, et al. J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):e15-e21. doi: 10.1093/jpids/piw035. J Pediatric Infect Dis Soc. 2017. PMID: 27451419 Free PMC article.
RESULTS: Intra-analyst variability was found to be relatively low among samples per assay, with only 6% (78 of 1240) having CV >20%, primarily with the highly concentrated immunoglobulin (Ig)G anti-pertussis toxin (PT) specimens and IgM assays. The rc measurements to as …
RESULTS: Intra-analyst variability was found to be relatively low among samples per assay, with only 6% (78 of 1240) having CV >20%, prim …
Comparing Pharmacist-Led Telehealth Care and Clinic-Based Care for Uncontrolled High Blood Pressure: The Hyperlink 3 Pragmatic Cluster-Randomized Trial.
Margolis KL, Bergdall AR, Crain AL, JaKa MM, Anderson JP, Solberg LI, Sperl-Hillen J, Beran M, Green BB, Haugen P, Norton CK, Kodet AJ, Sharma R, Appana D, Trower NK, Pawloski PA, Rehrauer DJ, Simmons ML, McKinney ZJ, Kottke TE, Ziegenfuss JY, Williams RA, O'Connor PJ. Margolis KL, et al. Hypertension. 2022 Dec;79(12):2708-2720. doi: 10.1161/HYPERTENSIONAHA.122.19816. Epub 2022 Oct 25. Hypertension. 2022. PMID: 36281763 Free PMC article. Clinical Trial.
Intravenous and Oral Tranexamic Acid Are Equivalent at Reducing Blood Loss in Thoracolumbar Spinal Fusion: A Prospective Randomized Trial.
Yu CC, Kadri O, Kadado A, Buraimoh M, Pawloski J, Bartol S, Graziano G. Yu CC, et al. Spine (Phila Pa 1976). 2019 Jun 1;44(11):755-761. doi: 10.1097/BRS.0000000000002954. Spine (Phila Pa 1976). 2019. PMID: 30540715 Clinical Trial.
METHODS: Eighty-three patients undergoing thoracolumbar fusion were randomized to receive 1.95 g of PO TXA 2 hours preoperatively or 2 g IV TXA (1 g before incision and 1 g before wound closure) intraoperatively. ...The mean reduction of hemoglobin was …
METHODS: Eighty-three patients undergoing thoracolumbar fusion were randomized to receive 1.95 g of PO TXA 2 hours preoperatively or …
26 results